Cripto-1: an embryonic gene that promotes tumorigenesis

Future Oncology
Nadia Pereira de CastroCaterina Bianco

Abstract

Several studies have shown that cell fate regulation during embryonic development and oncogenic transformation share common regulatory mechanisms and signaling pathways. Indeed, an embryonic gene member of the EGF-Cripto-1/FRL1/Cryptic family, Cripto-1, has been implicated in embryogenesis and in carcinogenesis. Cripto-1 together with the TGF-beta ligand Nodal is a key regulator of embryonic development and is a marker of undifferentiated human and mouse embryonic stem cells. While Cripto-1 expression is very low in normal adult tissues, Cripto-1 is re-expressed at high levels in several different human tumors, modulating cancer cell proliferation, migration, epithelial-to-mesenchymal transition and stimulating tumor angiogenesis. Therefore, inhibition of Cripto-1 expression using blocking antibodies or antisense expression vectors might be a useful modality not only to target fully differentiated cancer cells but also to target a subpopulation of tumor cells with stem-like characteristics.

References

Sep 1, 1991·Proceedings of the National Academy of Sciences of the United States of America·F CiardielloD S Salomon
Sep 1, 1991·Japanese Journal of Cancer Research : Gann·H KuniyasuD S Salomon
Feb 1, 1994·Japanese Journal of Cancer Research : Gann·M TsutsumiH Kitada
Mar 1, 1994·International Journal of Cancer. Journal International Du Cancer·H FriessM Korc
Jan 3, 1996·International Journal of Cancer. Journal International Du Cancer·L PanicoF Ciardiello
Oct 1, 1996·The Journal of Pathology·K FujiiE Tahara
Jan 1, 1997·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·H NiikuraA Yajima
Aug 7, 1997·International Journal of Cancer. Journal International Du Cancer·D PfeifferA Pfeiffer
Aug 26, 1998·The Journal of Pathology·R L ByrneF C Hamdy
Feb 6, 1999·International Journal of Cancer. Journal International Du Cancer·A De LucaN Normanno
Mar 20, 1999·The Journal of Biological Chemistry·C BiancoD S Salomon
Apr 14, 1999·Cell Death and Differentiation·C C NiemeyerE D Adamson
Nov 27, 1999·Current Biology : CB·U GaioC Birchmeier
Jul 8, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·D ErtoyA Ayhan
May 8, 2001·Experimental Cell Research·C WechselbergerD S Salomon
May 18, 2001·Nature·J Taipale, P A Beachy
May 23, 2001·Breast Cancer Research and Treatment·C BiancoD S Salomon
Sep 13, 2001·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·G BaldassarreM G Persico
Oct 27, 2001·Pflügers Archiv : European journal of physiology·U RajcevicR Komel
Nov 2, 2001·Nature·T ReyaI L Weissman
Mar 23, 2002·Molecular and Cellular Biology·Caterina BiancoDavid S Salomon
Jan 7, 2003·Genes & Development·Simon K ChengAlexander F Schier
Jan 18, 2003·International Journal of Cancer. Journal International Du Cancer·Thomas WelssHarry F Abts
Mar 12, 2003·Proceedings of the National Academy of Sciences of the United States of America·Muhammad Al-HajjMichael F Clarke
Apr 19, 2003·Proceedings of the National Academy of Sciences of the United States of America·Peter C GrayWylie Vale
May 6, 2003·Genes & Development·Luke T KrebsThomas Gridley
Aug 20, 2003·The Journal of Clinical Investigation·Heather B AdkinsMichele Sanicola
Feb 6, 2004·Development·Tetsuya Tabata, Yuki Takei
Feb 18, 2004·PLoS Biology·Simon K ChengAlexander F Schier
Apr 6, 2004·Current Biology : CB·Canhe Chen, Michael M Shen

❮ Previous
Next ❯

Citations

May 9, 2014·International Journal of Oncology·Emilia GiorgioGiovanna L Liguori
Dec 14, 2011·Growth Factors·Tadahiro NagaokaCaterina Bianco
Nov 16, 2010·Expert Opinion on Therapeutic Patents·Caterina Bianco, David S Salomon
Mar 13, 2016·Breast Cancer Research and Treatment·Maria Cristina RangelDavid S Salomon
Oct 17, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Chun HuangZhongxue Fu
Oct 20, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Bingbing WeiQiang Hu
Aug 26, 2014·Seminars in Cancer Biology·Malgorzata KlauzinskaDavid Salomon
May 1, 2012·The American Journal of Pathology·Maria C RangelCaterina Bianco
Mar 24, 2018·The Clinical Respiratory Journal·Chun Hua XuYong Lin
Nov 15, 2018·Journal of Cellular Biochemistry·Faisal AlowaidiStephen A Wood
Sep 13, 2018·Current Medicinal Chemistry·Annamaria Sandomenico, Menotti Ruvo
Jun 26, 2015·The International Journal of Biological Markers·Chun-Hua XuLi-Ke Yu
Jun 11, 2015·Oncotarget·Nadia P CastroDavid S Salomon
Apr 1, 2018·The Journal of Pathology·Sofia KarkampounaMarianna Kruithof-de Julio
Oct 7, 2016·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Yufang ZhaoWeiming Tian
Jan 3, 2018·Acta Biochimica Et Biophysica Sinica·Joachim NickelThomas D Mueller
Dec 20, 2018·BMC Cancer·Christopher N CultraraJenny Zilberberg
Nov 25, 2016·The Journal of Cell Biology·Gun-Hee LeeTaroh Kinoshita
Dec 18, 2020·Anais Da Academia Brasileira De Ciências·AndrÉ F SilvaJoabe S Pereira
Feb 12, 2021·International Journal of Molecular Sciences·Hiroko IshiiMasaharu Seno
Sep 10, 2021·Systems Biology in Reproductive Medicine·João Matheus BremmLucas Rosa Fraga

❮ Previous
Next ❯

Methods Mentioned

BETA
glycosylation
transgenic
antisense oligonucleotides
xenograft
xenografts
reverse transcription PCR

Related Concepts

Related Feeds

Cell Fate Specification

Cell fate specification is determined by complex signal transduction pathways including Notch and the Sonic hedgehog signaling pathway. Here is the latest research on regulation of cell fate determination.

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.